Catalyst Wire Dossier Catalyst Wire Dossier

RGTA (OTR4132)

OTR4132
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGTA (OTR4132), covering 2024-08-02 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS) [NA]

See pricing